Notice of Intent to issue a Sole Source Award to support development and validation of novel ARV detection methods.

PresolicitationNo Set AsideActive

Key Takeaways

  • Set-aside for No Set Aside businesses
  • Work to be performed in ATLANTA, GA
  • Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
  • Advance notice of upcoming solicitation

Contract Details

Notice ID
75D30126R73456
Opportunity Type
Presolicitation
Sub-Agency
CENTERS FOR DISEASE CONTROL AND PREVENTION
Office
CDC OFFICE OF ACQUISITION SERVICES
Posted Date
Monday, May 18, 2026
Response Deadline
Tuesday, June 2, 2026
PSC Code
AJ12
Set-Aside
No Set Aside
Place of Performance
ATLANTA, GA, 30333
Status
Active

Description

The Centers for Disease Control and Prevention Division of HIV Prevention (DHP)/Laboratory Branch (LB) intends to award a sole source firm fixed price purchase order to Emory University to support development and validation of novel ARV detection methods by obtaining freshly collected, matched biological specimens from individuals receiving ARVs for HIV treatment or prevention, and from individuals not receiving ARVs for developing assay controls. Emory University will collect fresh matched samples of whole blood and urine within the project timeline and deliver to CDC DHP Laboratory Branch staff within 24 hours of specimen collection to allow for CDCs analysis using research use only (RUO) assays that employ novel methods for measuring ARVs. CDC is assessing novel assays to provide result

Why This Opportunity Matters

HEALTH AND HUMAN SERVICES, DEPARTMENT OF is actively seeking qualified contractors for research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) with a set-aside for No Set Aside businesses in ATLANTA, GA. This set-aside designation means eligible businesses face reduced competition from larger firms.